文献速递生殖医学

医疗市场化:临床医生与患者对商业因素影响辅助生殖技术的看法

Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology.
PubMed 文献 · Reprod Biomed Online · 2024-01-29

本研究通过半结构化访谈,调查了澳大利亚和新西兰31名辅助生殖技术(ART)行业专家及澳大利亚25名ART患者对商业因素影响的看法。参与者认为商业力量在提升可持续性、标准一致性和患者选择方面有积极影响,但也导致政府和患者成本增加、缺乏充分证据的干预过度使用、知情同意不足及对医患关系的威胁。许多参与者认为需要监管改革和组织文化举措以确保患者福祉优先。

要点

  • 商业力量对ART有积极影响,包括增加可持续性、确保标准一致性和提供更多选择。
  • 商业力量也带来负面影响,如成本增加、缺乏充分证据的干预过度使用和知情同意不足。
  • 许多参与者认为需要监管改革和组织文化举措来确保患者福祉优先。

核心结论

  • 参与者认为商业力量对ART服务提供既有积极影响也有负面影响,许多参与者认为需要监管改革和组织文化举措以确保患者福祉优先。
  • 本研究的观点应被系统和批判性地审视,以获取关于如何最佳治理ART的见解,这些见解也可能为其他私营部门医疗保健的设计和提供提供参考。

研究设计与样本

  • 研究采用半结构化访谈,于2020年9月至2021年9月期间进行,纳入来自澳大利亚和新西兰的31名ART行业专家以及来自澳大利亚大都市和地区的25名正在接受ART的患者。
  • 数据分析采用主题分析。

主要发现

  • 专家和患者参与者认为商业力量以多种积极方式影响ART服务提供,包括增加可持续性、确保标准一致性和为患者提供更大选择。
  • 参与者还认为商业力量带来若干负面影响,包括政府和患者成本增加、过度使用缺乏足够证据被视为标准护理一部分的干预措施、知情同意不充分(特别是关于财务信息)以及对医患关系和以患者为中心的护理的威胁。
  • 参与者对专业自我监管是否足够的看法不一。
  • 许多参与者认为,在认识到商业投资对医疗保健益处的同时,需要进行监管改革以及组织文化举措,以确保患者福祉优先。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What are the views and experiences of patient and expert stakeholders on the positive and negative impacts of commercial influences on the provision of assisted reproductive technology (ART) services, and what are their suggestions for governance reforms? DESIGN: Semi-structured interviews were conducted with 31 ART industry experts from across Australia and New Zealand and 25 patients undergoing ART from metropolitan and regional Australia, between September 2020 and September 2021. Data were analysed using thematic analysis. RESULTS: Expert and patient participants considered that commercial forces influence the provision of ART in a number of positive ways - increasing sustainability, ensuring consistency in standards and providing patients with greater choice. Participants also considered commercial forces to have a number of negative impacts, including increased costs to government and patients; the excessive use of interventions that lack sufficient evidence to be considered part of standard care; inadequately informed consent (particularly with regard to financial information); and threats to patient-provider relationships and patient-centred care. Participants varied in whether they believed that professional self-regulation is sufficient. While recognizing the benefits of commercial investment in healthcare, many considered that regulatory reforms, as well as organizational cultural initiatives, are needed as means to ensure the primacy of patient well-being. CONCLUSIONS: The views expressed in this study should be systematically and critically examined to derive insights into how best to govern ART. These insights may also inform the design and delivery of other types of healthcare that are provided in the private sector.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Gallagher S, Attinger S, Sassano A, et al. Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology. Reprod Biomed Online. 2024. PMID: 38582042. doi:10.1016/j.rbmo.2024.103850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。